3P8-12300-72992 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-11
Dose 1 — Pfizer-BioNTech
2021-01-12
Registered in v-safe
2021-01-12
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work

Adult check-in
2021-01-12
Report sent to call center — days 1–6 daily, dose 1
Be unable to work

1 call case(s)
2021-01-13
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Chills

Adult check-in
2021-01-16
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Chills

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-18
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-25
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-01
Dose 2 — Pfizer-BioNTech
2021-02-01
Health check-in — day 0, dose 2
Feeling: Fair · Headache, Muscle or body aches

Adult check-in
2021-02-02
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-02-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fever · Chills · Be unable to work

Adult check-in
2021-02-05
Survey response — days 1–6 daily, dose 2
MedDRA: Hypersensitivity, Injection site erythema, Injection site hypersensitivity, Injection site warmth, Office visit — Feeling: Good · Site: Redness · Get care from a doctor or other healthcare professional

Free text: Systemic reaction (other): Developed a hypersensitivity reaction, 2.5 inches below the site of injection. Erythemateous and warm, is beginning to resolve, was discovered yesterday morning. · Healthcare visit (other): Evaulation by a physician I work with for the hypersensitivity reaction.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-05
Report sent to call center — days 1–6 daily, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-15
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-24
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-02
Survey response — day 28, dose 2
MedDRA: Breast pain, Pre-existing disease — Feeling: Good

Free text: I have had bilateral breast soreness for 2 days, which is unusual for me. Of note, I had a hysterectomy 7 years ago so it is not due to menstrual cycle. But the tenderness is reminiscent of my menstrual cycle symptoms.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-08
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-15
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-30
Call 1 — Left Voicemail
2021-08-04
Survey response — 6 months, dose 2
MedDRA: Breast pain, Mammogram abnormal, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional

Free text: Symptoms: Abnormality of left breast on routine mammogram. Being recalled for diagnostic imaging of left breast. Have had bilateral breast pain approx 2 weeks post #2 injection. Injections were bilateral. · Healthcare visit (other): Diagnostic imaging

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-04
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-15
Call 1 — Left Voicemail
2021-08-18
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-11	Pfizer-BioNTech
2	2021-02-01	Pfizer-BioNTech

Call center

3 call center cases

2 successful · 1 priority 2/3 (triaged and no follow up)

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 2

2021-02-05

Systemic reaction (other): Developed a hypersensitivity reaction, 2.5 inches below the site of injection. Erythemateous and warm, is beginning to resolve, was discovered yesterday morning.

Healthcare visit (other): Evaulation by a physician I work with for the hypersensitivity reaction.

Release 4 — day 28, dose 2

2021-03-02

Symptoms: I have had bilateral breast soreness for 2 days, which is unusual for me. Of note, I had a hysterectomy 7 years ago so it is not due to menstrual cycle. But the tenderness is reminiscent of my menstrual cycle symptoms.

Release 9 — 6 months, dose 2

2021-08-04

Symptoms: Abnormality of left breast on routine mammogram. Being recalled for diagnostic imaging of left breast. Have had bilateral breast pain approx 2 weeks post #2 injection. Injections were bilateral.

Healthcare visit (other): Diagnostic imaging

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Hypersensitivity	✓	✓	✓
HCVO	Office visit	✓	✓	✓
HCVO	Unevaluable event	✓	·	✓
SD	Breast pain	✓	✓	✓
SD	Mammogram abnormal	✓	·	✓
SD	Pre-existing disease	✓	✓	✓
SRO	Injection site erythema	✓	✓	✓
SRO	Injection site hypersensitivity	✓	✓	✓
SRO	Injection site warmth	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release